Obstructive sleep apnea (OSA) is a common sleep-breathing disorder with a high global prevalence that varies by region [1][2][3]. It is associated with impaired work performance, an increased rate of accidents, and many systemic conditions such as cardiovascular diseases, stroke, and abnormal glucose metabolism [4,5]. OSA is common at older ages, its consequences substantially impact older than younger adults [6]. Hence, providing patients with OSA with an effective treatment modality can be beneficial on many fronts.Various treatment options are available according to the complexity and severity of OSA [5,7] and among the options, mandibular advancement devices (MAD) have proven to be efficient and J Prosthodont Res. 2024; **(**):